首页 >
法规速递
-
Document: Agenda of the COMP Meeting 11-12 May 2026-2026/5/11
2026-05-12查看详情 > -
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products-2026/6/24
2026-06-24查看详情 > -
国家药监局药审中心关于发布《他达拉非片生物等效性研究技术指导原则》的通告（2022年第44号）-2022/11/25
2022-11-25查看详情 > -
国家药监局综合司 海关总署办公厅关于增设泰州市泰州港口岸为药品进口口岸有关事宜的通知 药监综药注〔2023〕82号-2023/11/7
2023-11-15查看详情 > -
Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2025/2/20
2025-02-21查看详情 > -
Document: Template for response to list of questions/list of outstanding issues: Quality / Non-clinical / Clinical-2025/3/28
2025-04-01查看详情 > -
Document: Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2-2025/5/6
2025-05-07查看详情 > -
Page: Questions and answers for biological medicinal products-2025/6/16
2025-06-17查看详情 > -
Document: European Medicines Agency Write PMS API implementation Guide (zip)-2025/7/18
2025-07-21查看详情 > -
Document: Rules for reimbursement of expenses for delegates attending meetings with effect from 17 March 2023-2025/9/3
2025-09-04查看详情 >
